Showing 63,061 - 63,080 results of 224,509 for search '(( a ((((larger decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.71s Refine Results
  1. 63061

    Data_Sheet_1_Harbor Porpoise (Phocoena phocoena) Reaction to a 3D Seismic Airgun Survey in the North Sea.docx by Joanna Sarnocińska (8319408)

    Published 2020
    “…Decreases in echolocation signals were detected up to 8–12 km from the active airguns, which may indicate temporary displacement of porpoises or a change in porpoise echolocation behavior. …”
  2. 63062

    Image_2_Not your usual neurodegenerative disease: a case report of neuronal intranuclear inclusion disease with unconventional imaging patterns.jpeg by Luyao Xu (3987749)

    Published 2023
    “…</p>Case presentation<p>A 39-year-old man presented with chronic headache, blurred vision, tinnitus, and numbness in the hands as initial symptoms, accompanied by cognitive slowing and decreased memory. …”
  3. 63063

    Intrathecal (i.t.) injection of ephrinB1-Fc produced a dose- and time-dependent hyperalgesia and spinal Fos protein expression. by Li-Na Yu (312492)

    Published 2013
    “…Inset figures showed that the calculated area under the curve (AUC) (−2–48 h) in paw-withdrawal latency (PWL) and paw-withdrawal threshold (PWT) test was significantly decreased in a dose-dependent manner in ephrinB1-Fc group. …”
  4. 63064

    Influence of Erythropoietin on Cognitive Performance during Experimental Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Randomized Cross-Over Trial by Peter Lommer Kristensen (399981)

    Published 2013
    “…</p> <p>Trial Registration</p><p>ClinicalTrials.gov <a href="http://clinicaltrials.gov/ct2/show/NCT00615368" target="_blank">NCT00615368</a></p> </div>…”
  5. 63065

    A <sup>1</sup>H-NMR Based Study on Hemolymph Metabolomics in Eri Silkworm after Oral Administration of 1-Deoxynojirimycin by Ming-Jie Deng (765440)

    Published 2015
    “…DNJ is a secure substance as a single-ingredient antidiabetic medicine due to its nontoxicity and bioactivity.…”
  6. 63066

    Overexpression of a <i>Triticum aestivum</i> Calreticulin gene (<i>TaCRT1</i>) Improves Salinity Tolerance in Tobacco by Yang Xiang (35912)

    Published 2015
    “…The calcium-binding properties of the purified recombinant <i>TaCRT1</i> protein were determined using a PIPES/Arsenazo III analysis. <i>TaCRT1</i> gene overexpression in <i>Nicotiana tabacum</i> decreased salt stress damage in transgenic tobacco plants. …”
  7. 63067

    DataSheet6_Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study.pdf by Yongming Du (807059)

    Published 2024
    “…</p>Conclusion<p>This comprehensive MR analysis indicated that SLE, CeD, vitiligo, and AD caused an increased risk of POI, SIgAD was associated with a decreased risk of POI. These insights carry profound clinical implications, particularly emphasizing the early intervention for women with AIDs/POI who wish to preserve their reproductive potential or plan for future pregnancies.…”
  8. 63068

    High-concentration carbamide peroxide can reduce the sensitivity caused by in-office tooth bleaching: a single-blinded randomized controlled trial by Aline Carvalho PEIXOTO (5379359)

    Published 2018
    “…<div><p>Abstract Objectives A single-blinded, randomized, parallel clinical trial evaluated the use of 37% carbamide peroxide (CP) on bleaching effectiveness and tooth sensitivity reported by patients undergoing in-office tooth bleaching, in comparison with the results of using 35% hydrogen peroxide. …”
  9. 63069

    DataSheet1_Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study.pdf by Yongming Du (807059)

    Published 2024
    “…</p>Conclusion<p>This comprehensive MR analysis indicated that SLE, CeD, vitiligo, and AD caused an increased risk of POI, SIgAD was associated with a decreased risk of POI. These insights carry profound clinical implications, particularly emphasizing the early intervention for women with AIDs/POI who wish to preserve their reproductive potential or plan for future pregnancies.…”
  10. 63070

    Table_1_Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population.XLSX by Bo-Hyun Kim (1766896)

    Published 2023
    “…These SNPs are involved in decreasing hippocampal volume and cognitive scores by mediating Aβ uptake. …”
  11. 63071

    Plasma concentration of selected biochemical markers of endothelial dysfunction in women with various severity of chronic venous insufficiency (CVI)—A pilot study by Magdalena Budzyń (4804326)

    Published 2018
    “…A significant rise of sTM was observed especially in CVI women, with the highest inflammation status reflected by hsCRP or elastase concentration, and in CVI women with a high oxidative stress manifested by an increased plasma MDA. …”
  12. 63072

    Supplementary Material for: Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel by Cooper N. (10503800)

    Published 2021
    “…<b><i>Background:</i></b> Recent evidence suggests that in patients with immune thrombocytopenia (ITP) with a stable response on thrombopoietin receptor agonists, treatment may be tapered and/or discontinued. …”
  13. 63073

    Image_1_Anti-Inflammatory (M2) Response Is Induced by a sp2-Iminosugar Glycolipid Sulfoxide in Diabetic Retinopathy.pdf by Fátima Cano-Cano (10322534)

    Published 2021
    “…Here we report the beneficial effect of (S<sub>S</sub>,1R)-1-docecylsulfiny-5N,6O-oxomethylidenenojirimycin ((Ss)-DS-ONJ), a member of the sp<sup>2</sup>-iminosugar glycolipid (sp<sup>2</sup>-IGL) family, by decreasing iNOS and inflammasome activation in Bv.2 microglial cells exposed to pro-inflammatory stimuli. …”
  14. 63074
  15. 63075

    Table4_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…Time-to-onset and univariate logistic regression analysis were performed to describe the characteristics and risk factors of oxaliplatin-associated neurological adverse events.</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  16. 63076

    Data_Sheet_1_Graphene Nanoplatelets Render Poly(3-Hydroxybutyrate) a Suitable Scaffold to Promote Neuronal Network Development.pdf by Matteo Moschetta (11453731)

    Published 2021
    “…Interestingly, a low concentration of graphene was able to promote firing activity at a low level of injected current. …”
  17. 63077

    Image3_Periplaneta americana extract alleviates steatohepatitis in a mouse model by modulating HMGB1-mediated inflammatory response.tif by Yang Xiao (146335)

    Published 2022
    “…Periplaneta americana has a long history of being applied in medicine, including wound healing, antitumor, antibacterial, antiviral, antifibrotic, and cardiomyocyte-protecting. …”
  18. 63078

    Replacement of glutamine residues in position 559 and 563 results in STAT1 mutants with a prolonged IFNγ-induced nuclear accumulation. by Bettina Hüntelmann (566945)

    Published 2014
    “…(C) Indirect fluorescence microscopy confirming the decreased nuclear export rates of STAT1-E559A and -E563A. …”
  19. 63079

    Additional file 3 of Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review by Sara Colomer-Lahiguera (9135962)

    Published 2020
    “…The PRO instruments used in each ICI-CT is shown. For a detailed PRO instrument content, see Table S8. …”
  20. 63080

    Table2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…Time-to-onset and univariate logistic regression analysis were performed to describe the characteristics and risk factors of oxaliplatin-associated neurological adverse events.</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”